Phuvamin Suriyaamporn, Boonnada Pamornpathomkul, Tanasait Ngawhirunpat, Prasert Akkaramongkolporn, Praneet Opanasopit
OBJECTIVE: This review article outlines the transformative impact of Artificial Intelligence (AI) in the pharmaceutical sciences, focusing on its integration with modern technologies and its role in advancing medication research, development, production, and digital transformation. SIGNIFICANCE: AI, through its synergy with machine learning (ML), deep learning (DL), and Industry 4.0 technologies such as the Internet of Things (IoT), robotics, blockchain, and digital twins, is pivotal in advancing personalized healthcare and adaptive manufacturing processes. METHODS: This article reviews AI technologies to analyze complex datasets, enhancing real-time decision-making, predictive analytics, and supply chain optimization. This approach allows for the development of personalized medicines using genomic, clinical, and environmental data. RESULTS: The application of AI has significantly improved operational efficiency and facilitated the tailored production of medications. However, challenges such as data privacy, algorithmic bias, and the need for updated regulations remain prevalent. CONCLUSIONS: Addressing these issues through ethical frameworks and comprehensive training is essential. The ongoing evolution of AI promises to bolster digital transformation, promote sustainable manufacturing, and improve global healthcare outcomes, setting a course toward innovation and patient-centric solutions in pharmaceutical sciences.